Bendazac
In Stock•Starting at $12 for 250 mg•Purity ≥ 95%
| CAS No. | 20187-55-7 |
|---|---|
| MDL No. | MFCD00866158 |
| MF | C16H14N2O3 |
| MW | 282.29 |
| InChI Key | BYFMCKSPFYVMOU-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 250 mg | 98% | $12 | In Stock | |
| 1 g | 98% | $22 | In Stock | |
| 5 g | 98% | $51 | In Stock | |
| 25 g | 98% | $138 | In Stock | |
| 100 g | 95% | $461 | In Stock |
Product Information
Bendazac is a monocarboxylic acid derived from glycolic acid, with the hydrogen of the 2-hydroxy group replaced by a 1-benzyl-1H-indazol-3-yl group. It exhibits anti-inflammatory, antinecrotic, choleretic, and antilipidaemic properties, and is used in treating inflammatory skin disorders. Its primary function is inhibiting protein denaturation. The lysine salt is used in cataract management. It acts as a radical scavenger and a non-steroidal anti-inflammatory drug, and is classified as an indazole and a monocarboxylic acid.
| CAS No. | 20187-55-7 |
|---|---|
| Product Name | Bendazac |
Biological Targets
XDH
Associated Conditions
eye inflammation·Myalgia·Arthralgia
* The information provided here is compiled from public sources and is for reference only.
